Decrease  ||| S:0 E:9 ||| NN
in  ||| S:9 E:12 ||| IN
Candida  ||| S:12 E:20 ||| NNP
bloodstream  ||| S:20 E:32 ||| NN
infections  ||| S:32 E:43 ||| NNS
in  ||| S:43 E:46 ||| IN
veterans  ||| S:46 E:55 ||| NNS
in  ||| S:55 E:58 ||| IN
Atlanta  ||| S:58 E:66 ||| NNP
Despite  ||| S:66 E:74 ||| IN
the  ||| S:74 E:78 ||| DT
recent  ||| S:78 E:85 ||| JJ
focus  ||| S:85 E:91 ||| NN
on  ||| S:91 E:94 ||| IN
prevention  ||| S:94 E:105 ||| NN
of  ||| S:105 E:108 ||| IN
health  ||| S:108 E:115 ||| NN
care-associated  ||| S:115 E:131 ||| JJ
infections ||| S:131 E:141 ||| NNS
,  ||| S:141 E:143 ||| ,
rates  ||| S:143 E:149 ||| NNS
of  ||| S:149 E:152 ||| IN
Candida  ||| S:152 E:160 ||| NNP
bloodstream  ||| S:160 E:172 ||| NN
infections  ||| S:172 E:183 ||| NNS
in  ||| S:183 E:186 ||| IN
adults  ||| S:186 E:193 ||| NNS
have  ||| S:193 E:198 ||| VBP
remained  ||| S:198 E:207 ||| VBN
unchanged  ||| S:207 E:217 ||| JJ
until  ||| S:217 E:223 ||| IN
recently ||| S:223 E:231 ||| RB
.  ||| S:231 E:233 ||| .
We  ||| S:233 E:236 ||| PRP
report  ||| S:236 E:243 ||| VBP
a  ||| S:243 E:245 ||| DT
decline  ||| S:245 E:253 ||| NN
of  ||| S:253 E:256 ||| IN
Candida  ||| S:256 E:264 ||| NNP
bloodstream  ||| S:264 E:276 ||| NN
infections ||| S:276 E:286 ||| NNS
,  ||| S:286 E:288 ||| ,
not  ||| S:288 E:292 ||| RB
explained  ||| S:292 E:302 ||| VBN
by  ||| S:302 E:305 ||| IN
changes  ||| S:305 E:313 ||| NNS
in  ||| S:313 E:316 ||| IN
broad-spectrum  ||| S:316 E:331 ||| JJ
antibiotic  ||| S:331 E:342 ||| JJ
use ||| S:342 E:345 ||| NN
,  ||| S:345 E:347 ||| ,
but  ||| S:347 E:351 ||| CC
coinciding  ||| S:351 E:362 ||| NN
with  ||| S:362 E:367 ||| IN
infection  ||| S:367 E:377 ||| NN
control  ||| S:377 E:385 ||| NN
policies  ||| S:385 E:394 ||| NNS
aimed  ||| S:394 E:400 ||| VBN
at  ||| S:400 E:403 ||| IN
central  ||| S:403 E:411 ||| JJ
venous  ||| S:411 E:418 ||| JJ
catheter  ||| S:418 E:427 ||| NN
maintenance ||| S:427 E:438 ||| NN
.  ||| S:438 E:440 ||| .
